Back on the scent: the olfactory system in CNS demyelinating diseases

被引:27
|
作者
Joseph, Albert [1 ]
DeLuca, Gabriele C. [2 ]
机构
[1] St Marys Hosp, Fdn Sch Off, London, England
[2] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Level 1 West Wing, Oxford OX3 9DU, England
关键词
MULTIPLE-SCLEROSIS; NEURODEGENERATIVE DISEASE; CORTICAL DEMYELINATION; PENNSYLVANIA SMELL; DYSFUNCTION; IDENTIFICATION; ASSOCIATION; PERFORMANCE; UNIVERSITY; DISORDER;
D O I
10.1136/jnnp-2015-312600
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Olfactory dysfunction is recognised across an ever broadening spectrum of neuropsychiatric conditions including central nervous system (CNS) demyelinating diseases such as multiple sclerosis (MS) and neuromyelitis optica (NMO). In this review, we unravel the striking evidence highlighting how olfactory loss is a common clinical feature in MS and NMO. We provide an overview of the supportive psychophysical, electrophysiological, radiological and pathological data that point to the anatomical substrate of olfactory deficits in these diseases. The pattern of underlying pathology affecting the olfactory system is shown to be complex, involving multiple structures that are affected in different ways throughout the course of the disease. This review is the first to synthesise the expanding body of literature on the topic, provides novel insight into the way in which the olfactory system is affected in CNS demyelinating diseases, and raises intriguing questions about the role of this system in the pathogenesis of these diseases.
引用
收藏
页码:1146 / 1154
页数:9
相关论文
共 50 条
  • [1] Olfactory Pathology in Central Nervous System Demyelinating Diseases
    DeLuca, Gabriele C.
    Joseph, Albert
    George, Jithin
    Yates, Richard L.
    Hamard, Marie
    Hofer, Monika
    Esiri, Margaret M.
    BRAIN PATHOLOGY, 2015, 25 (05) : 543 - 551
  • [2] The pathological spectrum of CNS inflammatory demyelinating diseases
    Hu, Wei
    Lucchinetti, Claudia F.
    SEMINARS IN IMMUNOPATHOLOGY, 2009, 31 (04) : 439 - 453
  • [4] MRI signs of CNS demyelinating diseases
    Etemadifar, Masoud
    Ashourizadeh, Helia
    Nouri, Hosein
    Kargaran, Parisa K.
    Salari, Mehri
    Rayani, Milad
    Aghababaee, Ali
    Abhari, Amir Parsa
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [5] The pathological spectrum of CNS inflammatory demyelinating diseases
    Wei Hu
    Claudia F. Lucchinetti
    Seminars in Immunopathology, 2009, 31 : 439 - 453
  • [6] Cerebrospinal fluid analysis in the context of CNS demyelinating diseases
    de Andrade Matas, Sandro Luiz
    von Glehn, Felipe
    Peres Fernandes, Gustavo Bruniera
    Senne Soares, Carlos Augusto
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (9B) : 685 - 688
  • [7] Primary CNS demyelinating diseases in childhood: Multiple sclerosis
    Iannetti, P
    Marciani, MG
    Spalice, A
    Spanedda, F
    Raucci, U
    Trasimeni, G
    Gualdi, GF
    Bernardi, G
    CHILDS NERVOUS SYSTEM, 1996, 12 (03) : 149 - 154
  • [8] Anterior optic pathway pathology in CNS demyelinating diseases
    Pisa, Marco
    Pansieri, Jonathan
    Yee, Sydney
    Ruiz, Jennifer
    Leite, Isabel M.
    Palace, Jacqueline
    Comi, Giancarlo
    Esiri, Margaret M.
    Leocani, Letizia
    DeLuca, Gabriele C.
    BRAIN, 2022, 145 (12) : 4308 - 4319
  • [9] Transplantation of olfactory ensheathing cells for treatment of inflammatory demyelinating diseases in the central nervous system
    Wu, Weijiang
    Lan, Qing
    Lu, Hua
    Xu, Jie
    Zhu, Aihua
    Fang, Wenfeng
    Jiang, Yunzhao
    Hui, Guozhen
    SCIENTIFIC RESEARCH AND ESSAYS, 2010, 5 (23): : 3676 - 3681
  • [10] Clinical use of CSF neopterin levels in CNS demyelinating diseases
    Miyaue, Noriyuki
    Hosokawa, Yuko
    Yamanishi, Yuki
    Tada, Satoshi
    Ando, Rina
    Nagai, Masahiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 441